|
(A)
|
|
GO_BP
|
GO:0002376~immune system process
|
8
|
1.63E−07
|
C1QA, C1QB, CD86, LY86, FCGR1, THEMIS2, C1QC, CLEC4N
|
|
GO:0045576~mast cell activation
|
4
|
3.83E−07
|
CD48, FYB, FCGR2B, FCGR3
|
|
GO:0045087~innate immune response
|
7
|
4.62E−06
|
C1QA, C1QB, CYBB, LY86, FCGR1, C1QC, CLEC4N
|
|
GO:0006911~phagocytosis, engulfment
|
4
|
1.86E−05
|
FCGR2B, AIF1, FCGR1, FCGR3
|
|
GO:0006954~inflammatory response
|
5
|
5.96E−04
|
CYBB, AIF1, LY86, THEMIS2, CCL6
|
|
PATHWAY
|
mmu05150:Staphylococcus aureus infection
|
7
|
2.59E−10
|
C1QA, C1QB, FCGR2B, FCGR4, FCGR1, C1QC, FCGR3
|
|
mmu05322:Systemic lupus erythematosus
|
6
|
6.02E−06
|
C1QA, C1QB, CD86, FCGR4, FCGR1, C1QC
|
|
mmu04145:Phagosome
|
6
|
1.37E−05
|
CYBB, FCGR2B, FCGR4, CTSS, FCGR1, FCGR3
|
|
mmu05152:Tuberculosis
|
6
|
1.45E−05
|
FCGR2B, IL10RA, FCGR4, CTSS, FCGR1, FCGR3
|
|
mmu04380:Osteoclast differentiation
|
5
|
8.03E−05
|
CYBB, FCGR2B, FCGR4, FCGR1, FCGR3
|
|
(B)
|
|
GO_BP
|
GO:0016125~sterol metabolic process
|
8
|
4.60E−14
|
CYP51, LDLR, HMGCR, FDPS, HMGCS1, SREBF2, SC4MOL, DHCR24
|
|
GO:0008202~steroid metabolic process
|
9
|
5.23E−14
|
CYP51, LDLR, HMGCR, FDPS, HMGCS1, LSS, SREBF2, SC4MOL, DHCR24
|
|
GO:0008203~cholesterol metabolic process
|
7
|
6.80E−12
|
CYP51, LDLR, HMGCR, FDPS, HMGCS1, SREBF2, DHCR24
|
|
GO:0006694~steroid biosynthetic process
|
7
|
7.42E−12
|
CYP51, HMGCR, FDPS, HMGCS1, LSS, SC4MOL, DHCR24
|
|
GO:0016126~sterol biosynthetic process
|
6
|
1.69E−11
|
CYP51, HMGCR, FDPS, HMGCS1, SC4MOL, DHCR24
|
|
PATHWAY
|
mmu00100:Steroid biosynthesis
|
5
|
1.10E−08
|
CYP51, SQLE, LSS, SC4MOL, DHCR24
|
|
mmu00900:Terpenoid backbone biosynthesis
|
3
|
2.46E−04
|
HMGCR, FDPS, HMGCS1
|
